In our future projects, genetic animal models [85, 86], patient-derived xenografts models, and organoid models, may help to further understanding the impact of PINK1-PTEN axis on ovarian cancer and determine more effective treatments for ovarian cancer patients. This evidence concerns the gene PINK1 and ovarian cancer.